ArticleBMC infectious diseases2026
Association of Helicobacter pylori infection with elevated low-density lipoprotein cholesterol and fasting glucose: a large-scale analysis of 83,054 participants in central China.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHelicobacter pylori (H. pylori) infection is increasingly recognized for its extragastric metabolic effects. However, its specific association with lipid and glucose dysregulation remains controversial. This study aimed to quantify the independent association between H. pylori infection and key metabolic markers, particularly LDL-C and fasting glucose, in a large-scale Chinese cohort.
methodsThis retrospective cross-sectional study analyzed 83,054 participants from a health management center in a central Chinese city (2021-2025). H. pylori status was determined by the
resultsThe overall H. pylori prevalence was 26.55%, with an age-specific peak of 28.80% in the 50-54 cohort. After multivariable adjustment, elevated LDL-C emerged as the strongest independent correlate of H. pylori presence (aOR = 1.34, 95% CI: 1.27-1.41, P< .001). Furthermore, fasting glucose was significantly associated with higher odds of being H. pylori positive (aOR = 1.04, 95% CI: 1.03-1.05, P < .001). In unadjusted analyses, total cholesterol was also significantly higher in the H. pylori-positive group (P = .005); however, in the multivariable model its independent association was attenuated after adjustment for LDL-C (see Table 2).
conclusionH. pylori infection is independently associated with elevated LDL-C and fasting glucose in this large urban population. These findings underscore the role of H. pylori as a systemic metabolic stressor and suggest that H. pylori eradication may offer collateral benefits for cardiovascular and metabolic risk management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.